10-QFiled 6 Nov 2026Banks
Sharplink, Inc.SBET
Quarterly report (10-Q), period ending 30 Sep 2026
No notable change in AIR's read.
The nightly ledger
Every 8-K, 10-Q and 10-K that AIR's companies filed on SEC EDGAR, and what each one changed in AIR's read. Material filings first, newest first — never ordered by price. For 8-K filing alerts, follow a company and turn on filing emails.
By event type: Acquisitions · Major contracts
Seven-day window, 2 weeks back · Material filings: 1629 · All filings: 1839
Friday 6 Nov249 filings read · 217 material
10-QFiled 6 Nov 2026Banks
Sharplink, Inc.SBET
Quarterly report (10-Q), period ending 30 Sep 2026
No notable change in AIR's read.
10-QFiled 6 Nov 2026Industrials
Quarterly report (10-Q), period ending 25 Sep 2026
No notable change in AIR's read.
8-KFiled 6 Nov 2026Banks
8-K · Item 2.02 — Results of operations
Q3 2026 net income of $26.4M (+4.1% YoY), core net income $30.0M (+11.5% YoY). Loan production $911.3M (+23.3% YoY), portfolio NIM improved to 3.78% (+13 bps). Book value per share up 17.9% YoY to $19.23.
More of the market is starting to notice.
Progress is running ahead of attention.
The price trend strengthened.
10-QFiled 6 Nov 2026All industries
Fidelity National Financial, Inc.FNF
Quarterly report (10-Q), period ending 30 Sep 2026
More of the market is starting to notice.
The price trend strengthened.
10-QFiled 6 Nov 2026Software / SaaS
Quarterly report (10-Q), period ending 30 Sep 2026
Progress is running ahead of attention.
The price trend strengthened.
10-QFiled 6 Nov 2026All industries
Quarterly report (10-Q), period ending 30 Sep 2026
Progress is running ahead of attention.
The price trend strengthened.
10-QFiled 6 Nov 2026All industries
HA Sustainable Infrastructure Capital, Inc.HASI
Quarterly report (10-Q), period ending 30 Sep 2026
No notable change in AIR's read.
8-KFiled 6 Nov 2026Biotech
8-K · Item 2.02 — Results of operations
Immunocore reported Q3 2026 KIMMTRAK net revenues of $102.2M (10% YoY growth normalized). Phase 3 TEBE-AM trial fully enrolled (540 patients); OS data expected Q2 2027. Promising Phase 1 data on KIMMTRAK plus brenetafusp combination. First type 1 diabetes patient dosed in IMC-S118AI trial. Cash position $901M.
More of the market is starting to notice.
Progress is running ahead of attention.
The price trend strengthened.
8-KFiled 6 Nov 2026All industries
8-K · Item 2.02 — Results of operations
Q3 2026 earnings show multifamily portfolio stabilization post-federal job cuts, with occupancy recovery and rent growth resuming. Office leasing momentum accelerates, particularly in defense-tech sectors. Company recapitalizes office assets with private partners and continues share repurchases.
Progress is running ahead of attention.
The price trend strengthened.
10-QFiled 6 Nov 2026Software / SaaS
Consensus Cloud Solutions, Inc.CCSI
Quarterly report (10-Q), period ending 30 Sep 2026
More of the market is starting to notice.
The shares became dearer on AIR's value read.
Progress is running ahead of attention.
The price trend strengthened.
10-QFiled 6 Nov 2026All industries
Quarterly report (10-Q), period ending 30 Sep 2026
The shares became dearer on AIR's value read.
The gap narrowed as the filings read less positively.
The price trend weakened.
10-QFiled 6 Nov 2026Industrials
Quarterly report (10-Q), period ending 2 Oct 2026
More of the market is starting to notice.
8-KFiled 6 Nov 2026All industries
8-K · Item 2.02 — Results of operations
Q3 2026 revenue declined 5.6% YoY to $289.3M; operating loss of $33.6M vs. $11.4M profit YoY; net loss $28.7M vs. $16.0M loss YoY. Adjusted EBITDA fell 16% to $82.2M. All segments showed revenue declines.
The shares became dearer on AIR's value read.
The gap narrowed as the filings read less positively.
The price trend weakened.
8-KFiled 6 Nov 2026All industries
U S Physical Therapy Inc /NVUSPH
8-K · Items 2.02, 8.01 — Results of operations
USPH reported Q3 2026 results on November 4, 2026, and declared a quarterly dividend of $0.46 payable December 11, 2026. The 8-K filing itself contains no substantive financial data or operational details.
More of the market is starting to notice.
The price trend strengthened.
10-QFiled 6 Nov 2026All industries
SmartStop Self Storage REIT, Inc.SMA
Quarterly report (10-Q), period ending 30 Sep 2026
Progress is running ahead of attention.
The price trend strengthened.
8-KFiled 6 Nov 2026All industries
Array Digital Infrastructure, Inc.AD
8-K · Item 2.02 — Results of operations
Array Digital Infrastructure reported Q3 2026 results with 14% YoY site rental revenue growth and consecutive quarter-over-quarter colocation growth. Company reaffirmed full-year 2026 guidance. Pending spectrum sales to T-Mobile received regulatory approval in October, expected to close in 2026.
No notable change in AIR's read.
8-KFiled 6 Nov 2026All industries
Interface IncTILE
8-K · Item 2.02 — Results of operations
Interface reported Q3 2026 results with modest net sales growth (0.6% YoY) but adjusted EPS growth of 11.5%. Company reaffirmed full-year earnings guidance while revising net sales outlook downward due to softer European conditions and delivery timing shifts.
Market attention has faded.
The price trend weakened.
10-QFiled 6 Nov 2026Banks
First Commonwealth Financial Corp /Pa/FCF
Quarterly report (10-Q), period ending 30 Sep 2026
No notable change in AIR's read.
10-QFiled 6 Nov 2026Banks
Quarterly report (10-Q), period ending 30 Sep 2026
The shares became cheaper on AIR's value read.
10-QFiled 6 Nov 2026Banks
Quarterly report (10-Q), period ending 30 Sep 2026
Progress is running ahead of attention.
8-KFiled 6 Nov 2026All industries
Brookdale Senior Living Inc.BKD
8-K · Item 2.02 — Results of operations
Q3 2026 net loss improved to $13.9M vs. $114.7M YoY, but Adjusted EBITDA guidance lowered to $495–502M from $502–516M. RevPAR growth guidance cut to 7.4–7.9% from 8.0–9.0% due to slower occupancy growth and a fire at a 97-unit community.
Market attention has faded.
The shares became cheaper on AIR's value read.
The gap closed as the filings read less positively.
The price trend weakened.
8-KFiled 6 Nov 2026All industries
8-K · Item 2.02 — Results of operations
Q3 2026 net income of $273.3M ($2.91 EPS) with Adjusted EBITDA of $347.2M. Specialty Products segment surged to $248.1M EBITDA (vs. $80.2M YoY). Montana Renewables delivered record earnings. Company retired $265M debt since July.
Market attention has faded.
Progress is running ahead of attention.
The price trend weakened.
10-QFiled 6 Nov 2026All industries
Quarterly report (10-Q), period ending 30 Sep 2026
Market attention has faded.
Progress is running ahead of attention.
The price trend weakened.
10-QFiled 6 Nov 2026Industrials
Gentex CorpGNTX
Quarterly report (10-Q), period ending 30 Sep 2026
No notable change in AIR's read.
10-QFiled 6 Nov 2026Biotech
Quarterly report (10-Q), period ending 30 Sep 2026
Market attention has faded.
Progress is running ahead of attention.
The price trend weakened.
10-QFiled 6 Nov 2026Software / SaaS
Grindr Inc.GRND
Quarterly report (10-Q), period ending 30 Sep 2026
No notable change in AIR's read.
8-KFiled 6 Nov 2026All industries
8-K · Item 2.02 — Results of operations
Franklin Templeton reported Q4 FY2026 net income of $380.1M ($0.72 EPS), up 223% YoY. Full-year net income reached $1,075.3M ($1.97 EPS), up 105% YoY. AUM grew 8% to $1.8T with $84.1B in full-year long-term net inflows across all regions and channels.
The reported numbers improved.
More of the market is starting to notice.
The shares became cheaper on AIR's value read.
Progress is running ahead of attention.
The price trend strengthened.
10-QFiled 6 Nov 2026Banks
Heritage Financial Corp /Wa/HFWA
Quarterly report (10-Q), period ending 30 Sep 2026
The shares became cheaper on AIR's value read.
The price trend weakened.
10-QFiled 6 Nov 2026All industries
Quarterly report (10-Q), period ending 29 Sep 2026
Market attention has faded.
Progress is running ahead of attention.
The price trend weakened.
10-QFiled 6 Nov 2026Biotech
Quarterly report (10-Q), period ending 30 Sep 2026
More of the market is starting to notice.
Progress is running ahead of attention.
The price trend strengthened.
10-QFiled 6 Nov 2026All industries
Medical Properties Trust IncMPT
Quarterly report (10-Q), period ending 30 Sep 2026
No notable change in AIR's read.
10-QFiled 6 Nov 2026All industries
Quarterly report (10-Q), period ending 30 Sep 2026
Progress is running ahead of attention.
10-QFiled 6 Nov 2026All industries
Viasat IncVSAT
Quarterly report (10-Q), period ending 30 Sep 2026
More of the market is starting to notice.
The shares became dearer on AIR's value read.
Progress is running ahead of attention.
The price trend strengthened.
10-QFiled 6 Nov 2026Banks
Quarterly report (10-Q), period ending 30 Sep 2026
The shares became cheaper on AIR's value read.
10-QFiled 6 Nov 2026Banks
Quarterly report (10-Q), period ending 30 Sep 2026
No notable change in AIR's read.
10-QFiled 6 Nov 2026Banks
Quarterly report (10-Q), period ending 30 Sep 2026
More of the market is starting to notice.
The price trend strengthened.
10-QFiled 6 Nov 2026All industries
Invesco Mortgage Capital Inc.IVR
Quarterly report (10-Q), period ending 30 Sep 2026
No notable change in AIR's read.
10-QFiled 6 Nov 2026Industrials
Quarterly report (10-Q), period ending 30 Sep 2026
Progress is running ahead of attention.
The price trend weakened.
10-QFiled 6 Nov 2026Industrials
Quarterly report (10-Q), period ending 3 Oct 2026
Market attention has faded.
The shares became cheaper on AIR's value read.
Progress is running ahead of attention.
The price trend weakened.
10-QFiled 6 Nov 2026Software / SaaS
Next Technology Holding Inc.NXTT
Quarterly report (10-Q), period ending 30 Sep 2026
More of the market is starting to notice.
The price trend strengthened.
10-QFiled 6 Nov 2026Industrials
Harmonic Inc.HLIT
Quarterly report (10-Q), period ending 2 Oct 2026
No notable change in AIR's read.
10-QFiled 6 Nov 2026Banks
Quarterly report (10-Q), period ending 30 Sep 2026
The shares became cheaper on AIR's value read.
10-QFiled 6 Nov 2026Banks
Quarterly report (10-Q), period ending 30 Sep 2026
No notable change in AIR's read.
10-QFiled 6 Nov 2026All industries
Oklo Inc.OKLO
Quarterly report (10-Q), period ending 30 Sep 2026
No notable change in AIR's read.
10-QFiled 6 Nov 2026All industries
Quarterly report (10-Q), period ending 30 Sep 2026
Progress is running ahead of attention.
8-KFiled 6 Nov 2026All industries
8-K · Item 2.02 — Results of operations
MMI reported Q3 2026 revenue growth of 7.5% YoY to $208.4M, with net income of $0.03/share vs. $0.01/share prior year. Nine-month revenue up 14.0% to $582.8M; net income $0.05/share vs. loss of $0.39/share. Middle Market revenue surged 18.1%.
Market attention has faded.
Progress is running ahead of attention.
The price trend weakened.
8-KFiled 6 Nov 2026All industries
Hawaiian Electric Industries IncHE
8-K · Item 2.02 — Results of operations
No notable change in AIR's read.
10-QFiled 6 Nov 2026Banks
German American Bancorp, Inc.GABC
Quarterly report (10-Q), period ending 30 Sep 2026
The gap narrowed as the filings read less positively.
10-QFiled 6 Nov 2026Banks
Quarterly report (10-Q), period ending 30 Sep 2026
The shares became dearer on AIR's value read.
10-QFiled 6 Nov 2026All industries
Quarterly report (10-Q), period ending 30 Sep 2026
No notable change in AIR's read.
10-QFiled 6 Nov 2026Banks
First Mid Bancshares, Inc.FMBH
Quarterly report (10-Q), period ending 30 Sep 2026
The shares became cheaper on AIR's value read.
10-QFiled 6 Nov 2026Banks
Quarterly report (10-Q), period ending 30 Sep 2026
Market attention has faded.
8-KFiled 6 Nov 2026All industries
Sunstone Hotel Investors, Inc.SHO
8-K · Item 2.02 — Results of operations
Q3 2026 earnings significantly exceeded expectations with net income of $38.7M ($0.21/share) vs. prior-year loss, RevPAR growth of 11.4%, and Adjusted FFO per share up 17.6%. Company raised full-year 2026 guidance across all key metrics and completed $196.9M in accretive stock repurchases.
Market attention has faded.
Progress is running ahead of attention.
10-QFiled 6 Nov 2026Banks
Quarterly report (10-Q), period ending 30 Sep 2026
No notable change in AIR's read.
10-QFiled 6 Nov 2026Banks
First Community Bankshares Inc /Va/FCBC
Quarterly report (10-Q), period ending 30 Sep 2026
No notable change in AIR's read.
10-QFiled 6 Nov 2026Banks
Quarterly report (10-Q), period ending 30 Sep 2026
No notable change in AIR's read.
10-QFiled 6 Nov 2026Biotech
Allogene Therapeutics, Inc.ALLO
Quarterly report (10-Q), period ending 30 Sep 2026
Progress is running ahead of attention.
8-KFiled 6 Nov 2026All industries
8-K · Item 2.02 — Results of operations
Market attention has faded.
The shares became cheaper on AIR's value read.
The price trend weakened.
10-QFiled 6 Nov 2026All industries
Quarterly report (10-Q), period ending 30 Sep 2026
Progress is running ahead of attention.
10-QFiled 6 Nov 2026All industries
Quarterly report (10-Q), period ending 27 Sep 2026
Market attention has faded.
The shares became cheaper on AIR's value read.
The price trend weakened.
10-QFiled 6 Nov 2026All industries
Quarterly report (10-Q), period ending 30 Sep 2026
More of the market is starting to notice.
The price trend strengthened.
10-QFiled 6 Nov 2026All industries
Alpha Metallurgical Resources, Inc.AMR
Quarterly report (10-Q), period ending 30 Sep 2026
No notable change in AIR's read.
10-QFiled 6 Nov 2026All industries
Quarterly report (10-Q), period ending 30 Sep 2026
More of the market is starting to notice.
Progress is running ahead of attention.
The price trend strengthened.
10-QFiled 6 Nov 2026All industries
Quarterly report (10-Q), period ending 30 Sep 2026
Progress is running ahead of attention.
The price trend strengthened.
10-QFiled 6 Nov 2026All industries
Telephone & Data Systems Inc /De/TDS
Quarterly report (10-Q), period ending 30 Sep 2026
No notable change in AIR's read.
8-KFiled 6 Nov 2026All industries
Telephone & Data Systems Inc /De/TDS
8-K · Item 2.02 — Results of operations
No notable change in AIR's read.
10-QFiled 6 Nov 2026All industries
Quarterly report (10-Q), period ending 30 Sep 2026
Market attention has faded.
The gap closed as the filings read less positively.
The price trend weakened.
10-QFiled 6 Nov 2026Industrials
Quarterly report (10-Q), period ending 30 Sep 2026
Progress is running ahead of attention.
The price trend weakened.
10-QFiled 6 Nov 2026All industries
BXP, Inc.BXP
Quarterly report (10-Q), period ending 30 Sep 2026
No notable change in AIR's read.
10-QFiled 6 Nov 2026All industries
Quarterly report (10-Q), period ending 30 Sep 2026
No notable change in AIR's read.
8-KFiled 6 Nov 2026All industries
8-K · Item 2.02 — Results of operations
NHC reported Q3 2026 revenues of $408M (+6.6% YoY) and adjusted net income of $28.2M (+13.8% YoY). Growth driven by June and July 2026 acquisitions of 40 facilities with 5,464 beds. GAAP net income declined due to unrealized losses on equity securities.
Progress is running ahead of attention.
10-QFiled 6 Nov 2026Banks
Peapack Gladstone Financial CorpPGC
Quarterly report (10-Q), period ending 30 Sep 2026
No notable change in AIR's read.
8-KFiled 6 Nov 2026Biotech
8-K · Item 2.02 — Results of operations
CG Oncology reported Q3 2026 results with $984.5M cash runway through 2029. Key near-term catalysts include PIVOT-006 Phase 3 topline data (November 2026), two 12-month datasets (December 2026), and BLA completion (Q4 2026). Added experienced Chief Commercial Officer.
More of the market is starting to notice.
Progress is running ahead of attention.
The price trend strengthened.
10-QFiled 6 Nov 2026All industries
Amn Healthcare Services IncAMN
Quarterly report (10-Q), period ending 30 Sep 2026
Market attention has faded.
The shares became cheaper on AIR's value read.
Progress is running ahead of attention.
The price trend weakened.
10-QFiled 6 Nov 2026All industries
Quarterly report (10-Q), period ending 30 Sep 2026
More of the market is starting to notice.
Progress is running ahead of attention.
The price trend strengthened.
10-QFiled 6 Nov 2026All industries
Everus Construction Group, Inc.ECG
Quarterly report (10-Q), period ending 30 Sep 2026
Progress is running ahead of attention.
10-QFiled 6 Nov 2026All industries
Bowman Consulting Group Ltd.BWMN
Quarterly report (10-Q), period ending 30 Sep 2026
The filings read less positively.
The shares became dearer on AIR's value read.
10-QFiled 6 Nov 2026Industrials
Quarterly report (10-Q), period ending 30 Sep 2026
More of the market is starting to notice.
Progress is running ahead of attention.
The price trend strengthened.
10-QFiled 6 Nov 2026All industries
Tanger Inc.SKT
Quarterly report (10-Q), period ending 30 Sep 2026
Progress is running ahead of attention.
The price trend strengthened.
10-QFiled 6 Nov 2026Software / SaaS
Quarterly report (10-Q), period ending 30 Sep 2026
Market attention has faded.
10-QFiled 6 Nov 2026Banks
Quarterly report (10-Q), period ending 30 Sep 2026
No notable change in AIR's read.
10-QFiled 6 Nov 2026All industries
Hawaiian Electric Industries IncHE
Quarterly report (10-Q), period ending 30 Sep 2026
No notable change in AIR's read.
10-QFiled 6 Nov 2026All industries
Quarterly report (10-Q), period ending 30 Sep 2026
The shares became dearer on AIR's value read.
The gap narrowed — attention is catching up.
The price trend strengthened.
10-QFiled 6 Nov 2026All industries
Quarterly report (10-Q), period ending 30 Sep 2026
Progress is running ahead of attention.
The price trend weakened.
10-QFiled 6 Nov 2026Semiconductors
ALPHA & OMEGA SEMICONDUCTOR LtdAOSL
Quarterly report (10-Q), period ending 30 Sep 2026
The reported numbers improved.
The shares became dearer on AIR's value read.
Progress is running ahead of attention.
The price trend strengthened.
10-QFiled 6 Nov 2026Banks
Quarterly report (10-Q), period ending 30 Sep 2026
No notable change in AIR's read.
10-QFiled 6 Nov 2026All industries
Quarterly report (10-Q), period ending 30 Sep 2026
AIR measured this for the first time; no change to report.
The price trend strengthened.
10-QFiled 6 Nov 2026All industries
Yelp IncYELP
Quarterly report (10-Q), period ending 30 Sep 2026
The gap narrowed — attention is catching up.
10-QFiled 6 Nov 2026All industries
Quarterly report (10-Q), period ending 30 Sep 2026
More of the market is starting to notice.
Progress is running ahead of attention.
The price trend strengthened.
10-QFiled 6 Nov 2026All industries
Quarterly report (10-Q), period ending 30 Sep 2026
No notable change in AIR's read.
10-QFiled 6 Nov 2026All industries
Quarterly report (10-Q), period ending 30 Sep 2026
The shares became cheaper on AIR's value read.
10-QFiled 6 Nov 2026All industries
Quarterly report (10-Q), period ending 30 Sep 2026
Progress is running ahead of attention.
8-KFiled 6 Nov 2026All industries
8-K · Item 2.02 — Results of operations
Q3 2026 pre-tax operating earnings of $9.9M exceeded prior year ($6.9M). Nine-month net earnings of $26.4M vs. $12.4M YoY, driven by $22.1M investment gains. Steak n Shake same-store sales up 18.2%.
AIR measured this for the first time; no change to report.
The price trend strengthened.
10-QFiled 6 Nov 2026Biotech
Quarterly report (10-Q), period ending 30 Sep 2026
More of the market is starting to notice.
The price trend strengthened.
10-QFiled 6 Nov 2026All industries
Quarterly report (10-Q), period ending 30 Sep 2026
Market attention has faded.
Progress is running ahead of attention.
The price trend weakened.
10-QFiled 6 Nov 2026Banks
Quarterly report (10-Q), period ending 30 Sep 2026
The shares became cheaper on AIR's value read.
10-QFiled 6 Nov 2026Industrials
XPEL, Inc.XPEL
Quarterly report (10-Q), period ending 30 Sep 2026
Progress is running ahead of attention.
The price trend weakened.
10-QFiled 6 Nov 2026All industries
Quarterly report (10-Q), period ending 30 Sep 2026
Progress is running ahead of attention.
10-QFiled 6 Nov 2026Banks
Westamerica BancorporationWABC
Quarterly report (10-Q), period ending 30 Sep 2026
No notable change in AIR's read.
10-QFiled 6 Nov 2026All industries
York Water CoYORW
Quarterly report (10-Q), period ending 30 Sep 2026
The shares became cheaper on AIR's value read.
Progress is running ahead of attention.
The price trend weakened.
Sun 22 Nov
CAPR · Capricor Therapeutics, Inc. · Regulatory date
As stated in the filing: “Deramiocel Biologics License Application (BLA) for Duchenne muscular dystrophy (DMD) under FDA review; PDUFA target action date of November 22, 2026 ●”
Announced by the company in 8-K on 10 Nov 2026
DYN · Dyne Therapeutics, Inc. · Regulatory date
As stated in the filing: “Capricor Therapeutics’ BLA for its cell therapy deramiocel is currently under FDA review with a PDUFA date of November 22, 2026.”
Announced by the company in 10-Q on 5 Nov 2026
SVRA · Savara Inc · Regulatory date
As stated in the filing: “The FDA determined that the Company’s responses to recent information requests by the Agency during its review constituted a major amendment to the BLA, resulting in a three-month extension of the Prescription Drug User Fee Act ("PDUFA") target action date to November 22, 2026.”
Announced by the company in 10-Q on 9 Nov 2026
Fri 27 Nov
BBIO · BridgeBio Pharma, Inc. · Regulatory date
As stated in the filing: “The first participant was dosed in ASCEND-ATTR, the Phase 3b/4 study to prospectively test disease reversal with Attruby - BBP-418 for LGMD2I/R9 has a November 27, 2026 PDUFA date, with Priority Review.”
Announced by the company in 8-K on 29 Oct 2026
Mon 30 Nov
COGT · Cogent Biosciences, Inc. · Regulatory date
As stated in the filing: “Potential FDA approval of bezuclastinib in GIST – PDUFA date of November 30, 2026 •”
Announced by the company in 8-K on 5 Nov 2026
JBIO · Jade Biosciences, Inc. · Regulatory date
As stated in the filing: “The FDA has also accepted a Biologics License Application for accelerated approval of povetacicept in IgAN, with a Prescription Drug User Fee Act target action date of November 30, 2026.”
Announced by the company in 10-Q on 13 Nov 2026
Wed 2 Dec
ARE · Alexandria Real Estate Equities, Inc. · Investor day
As stated in the filing: “We expect to introduce 2027 guidance and related assumptions at our Investor Day on December 2, 2026, consistent with our historical practice.”
Announced by the company in 8-K on 27 Apr 2026
Thu 3 Dec
EXEL · Exelixis, Inc. · Regulatory date
As stated in the filing: “In February 2026, we announced that the FDA had accepted our NDA and assigned a standard review, with a Prescription Drug User Fee Act (PDUFA) target action date of December 3, 2026.”
Announced by the company in 10-Q on 29 Oct 2026
Tue 8 Dec
GPC · Genuine Parts Co · Investor day
As stated in the filing: “In addition, the Company announced that both Global Automotive and Global Industrial will host separate investor days on December 8, 2026 and December 9, 2026, respectively.”
Announced by the company in 8-K on 9 Sep 2026
LGND · Ligand Pharmaceuticals Inc · Investor day
As stated in the filing: “Ligand will provide an updated 5-year outlook during the Company’s Investor Day on December 8, 2026.”
Announced by the company in 8-K on 14 Jul 2026
Wed 9 Dec
GPC · Genuine Parts Co · Investor day
As stated in the filing: “Investor Days GPC and Motion will host separate investor days in New York City, with GPC’s Investor Day scheduled for December 8, 2026, and Motion’s Investor Day scheduled for December 9, 2026.”
Announced by the company in 8-K on 9 Sep 2026
Sat 12 Dec
ANAB · Anaptysbio, Inc · Regulatory date
As stated in the filing: “FDA target action date (PDUFA) of December 12, 2026, for Quimilza in generalized pustular psoriasis (GPP) GSK and Tesaro Litigation Update •”
Announced by the company in 8-K on 12 Nov 2026
Thu 17 Dec
CORT · Corcept Therapeutics Inc · Regulatory date
As stated in the filing: “Relacorilant for patients with Cushing’s syndrome – Resubmitted New Drug Application Prescription Drug User Fee Act (PDUFA) date of December 17, 2026 “The ADA and EASD consensus statement is an important advance for the many patients whose difficult-to-control hyperglycemia is a manifestation of undiagnosed Cushing’s syndrome,” said Bill Guyer, PharmD, Corcept’s Chief Development Officer.”
Announced by the company in 8-K on 3 Nov 2026
Mon 23 Nov
MATW · Matthews International Corp · All industries
Annual results due — last year filed 21 Nov 2025
Last quarter (Q3 2026, against a year earlier): revenue down 30%, net income turned to a loss
AIR's current read: News flow Balanced, Gap Low · 0
Tue 24 Nov
BLBD · Blue Bird Corp · Industrials
Annual results due — last year filed 24 Nov 2025
Last quarter (Q3 2026, against a year earlier): revenue up 30%, net income up 408%
AIR's current read: News flow Balanced, Gap Very high · 82
PFLT · PennantPark Floating Rate Capital Ltd. · All industries
Annual results due — last year filed 24 Nov 2025
AIR's current read: News flow Balanced, Gap Very high · 71
Wed 25 Nov
AMTM · Amentum Holdings, Inc. · All industries
Annual results due — last year filed 25 Nov 2025
Last quarter (Q3 2025, against a year earlier): revenue up 66%, net income turned positive
AIR's current read: News flow Balanced, Gap Low · 4
ARMK · Aramark · All industries
Annual results due — last year filed 25 Nov 2025
Last quarter (Q3 2025, against a year earlier): revenue up 6%, net income up 23%
AIR's current read: News flow Balanced, Gap Medium · 10
CASH · Pathward Financial, Inc. · Banks
Annual results due — last year filed 25 Nov 2025
Last quarter (Q3 2026, against a year earlier): revenue down 3%, net income down 31%
AIR's current read: News flow Balanced, Gap Low · 0
CLSK · Cleanspark, Inc. · Banks
Annual results due — last year filed 25 Nov 2025
Last quarter (Q3 2024, against a year earlier): revenue up 129%, net loss widened
AIR's current read: News flow Balanced, Gap Very high · 54
GAP · Gap Inc · All industries
Quarterly results due — last year filed 25 Nov 2025
Last quarter (Q3 2024, against a year earlier): revenue down 7%, net income down 23%
AIR's current read: News flow Balanced, Gap Low · 3
ROAD · Construction Partners, Inc. · All industries
Annual results due — last year filed 25 Nov 2025
Last quarter (Q3 2026, against a year earlier): revenue up 28%, net income up 35%
AIR's current read: News flow Balanced, Gap Low · 7
SJM · J M SMUCKER Co · All industries
Quarterly results due — last year filed 25 Nov 2025
Last quarter (Q3 2026, against a year earlier): revenue up 7%, net loss widened
AIR's current read: News flow Balanced, Gap Low · 7
SMG · Scotts Miracle-Gro Co · All industries
Annual results due — last year filed 25 Nov 2025
Last quarter (Q3 2026, against a year earlier): revenue up 1%, net income down 25%
AIR's current read: News flow Balanced, Gap Medium · 12
SMTC · Semtech Corp · Semiconductors
Quarterly results due — last year filed 25 Nov 2025
Last quarter (Q1 2027, against a year earlier): revenue up 16%, net income up 37%
AIR's current read: News flow Balanced, Gap Low · 0
TFSL · TFS Financial CORP · Banks
Annual results due — last year filed 25 Nov 2025
Last quarter (Q1 2019, against a year earlier): net income up 4%
AIR's current read: News flow Balanced, Gap Medium · 23
Fri 27 Nov
ATKR · Atkore Inc. · Industrials
Annual results due — last year filed 26 Nov 2025
Last quarter (Q3 2026, against a year earlier): revenue up 8%, net income down 98%
AIR's current read: News flow Balanced, Gap Low · 0
BJ · BJ's Wholesale Club Holdings, Inc. · All industries
Quarterly results due — last year filed 26 Nov 2025
Last quarter (Q2 2027, against a year earlier): revenue up 16%, net income up 15%
AIR's current read: News flow Balanced, Gap Medium · 18
CENT · Central Garden & Pet Co · All industries
Annual results due — last year filed 26 Nov 2025
Last quarter (Q3 2026, against a year earlier): revenue down 8%, net income down 5%
AIR's current read: News flow Balanced, Gap Low · 1
CFFN · Capitol Federal Financial, Inc. · Banks
Annual results due — last year filed 26 Nov 2025
Last quarter (Q3 2020, against a year earlier): net income down 15%
AIR's current read: News flow Balanced, Gap Medium · 10
JJSF · J&J Snack Foods Corp · All industries
Annual results due — last year filed 26 Nov 2025
Last quarter (Q3 2026, against a year earlier): revenue down 6%, net income down 20%
AIR's current read: News flow Balanced, Gap Low · 0
PD · PagerDuty, Inc. · Software / SaaS
Quarterly results due — last year filed 26 Nov 2025
Last quarter (Q1 2027, against a year earlier): revenue up 1%, net income turned positive
AIR's current read: News flow Balanced, Gap Low · 0
SPH · Suburban Propane Partners Lp · All industries
Annual results due — last year filed 26 Nov 2025
Last quarter (Q3 2026, against a year earlier): revenue unchanged, net loss widened
AIR's current read: News flow Balanced, Gap Medium · 21
UTI · Universal Technical Institute Inc · All industries
Annual results due — last year filed 26 Nov 2025
Last quarter (Q3 2026, against a year earlier): revenue up 7%, net income down 79%
AIR's current read: News flow Balanced, Gap Very high · 57
Mon 30 Nov
SNEX · StoneX Group Inc. · All industries
Annual results due — last year filed 28 Nov 2025
Last quarter (Q3 2026, against a year earlier): revenue up 15%, net income up 102%
AIR's current read: News flow Balanced, Gap Very high · 52
Tue 1 Dec
ESE · Esco Technologies Inc · Industrials
Annual results due — last year filed 1 Dec 2025
Last quarter (Q3 2026, against a year earlier): revenue up 14%, net income up 26%
AIR's current read: News flow Balanced, Gap Very high · 97
Wed 2 Dec
ASAN · Asana, Inc. · Software / SaaS
Quarterly results due — last year filed 2 Dec 2025
Last quarter (Q2 2027, against a year earlier): revenue up 10%, net loss narrowed
AIR's current read: News flow Balanced, Gap Low · 0
UNFI · United Natural Foods Inc · All industries
Quarterly results due — last year filed 2 Dec 2025
AIR's current read: News flow Balanced, Gap Low · 0
VSTS · Vestis Corp · All industries
Annual results due — last year filed 2 Dec 2025
Last quarter (Q3 2025, against a year earlier): revenue down 4%, net income turned to a loss
AIR's current read: News flow Balanced, Gap Low · 1
Thu 3 Dec
BOX · Box Inc · Software / SaaS
Quarterly results due — last year filed 3 Dec 2025
Last quarter (Q2 2027, against a year earlier): revenue up 9%, net income up 43%
AIR's current read: News flow Balanced, Gap Low · 1
CRWD · CrowdStrike Holdings, Inc. · Software / SaaS
Quarterly results due — last year filed 3 Dec 2025
Last quarter (Q1 2027, against a year earlier): revenue up 26%, net income turned positive
AIR's current read: News flow Balanced, Gap Low · 5
HQY · Healthequity, Inc. · All industries
Quarterly results due — last year filed 3 Dec 2025
Last quarter (Q2 2027, against a year earlier): revenue up 8%, net income up 10%
AIR's current read: News flow Balanced, Gap Low · 0
KSS · KOHLS Corp · All industries
Quarterly results due — last year filed 3 Dec 2025
Last quarter (Q3 2024, against a year earlier): revenue down 5%, net income down 39%
AIR's current read: News flow Balanced, Gap Medium · 11
MEI · Methode Electronics Inc · Industrials
Quarterly results due — last year filed 3 Dec 2025
AIR's current read: News flow Balanced, Gap Low · 0
NCNO · nCino, Inc. · Software / SaaS
Quarterly results due — last year filed 3 Dec 2025
Last quarter (Q1 2027, against a year earlier): revenue up 11%, net income up 145%
AIR's current read: News flow Balanced, Gap Low · 5
THO · Thor Industries Inc · Industrials
Quarterly results due — last year filed 3 Dec 2025
Last quarter (Q4 2026, against a year earlier): revenue down 8%, net income down 68%
AIR's current read: News flow Balanced, Gap Low · 4
Fri 4 Dec
AGX · Argan Inc · All industries
Quarterly results due — last year filed 4 Dec 2025
Last quarter (Q2 2027, against a year earlier): revenue up 62%, net income up 51%
AIR's current read: News flow Balanced, Gap Low · 9
AMBA · Ambarella Inc · Semiconductors
Quarterly results due — last year filed 4 Dec 2025
Last quarter (Q2 2027, against a year earlier): revenue up 13%, net loss narrowed
AIR's current read: News flow Balanced, Gap Low · 7
BF-B · Brown Forman Corp · All industries
Quarterly results due — last year filed 4 Dec 2025
Last quarter (Q1 2027, against a year earlier): revenue down 1%, net income up 4%
AIR's current read: News flow Balanced, Gap Low · 0
CXM · Sprinklr, Inc. · Software / SaaS
Quarterly results due — last year filed 4 Dec 2025
Last quarter (Q2 2027, against a year earlier): revenue up 1%, net income down 44%
AIR's current read: News flow Balanced, Gap Low · 9
DCI · DONALDSON Co INC · All industries
Quarterly results due — last year filed 4 Dec 2025
Last quarter (Q4 2026, against a year earlier): revenue up 8%, net income up 13%
AIR's current read: News flow Balanced, Gap Low · 9
FIVE · Five Below, Inc · All industries
Quarterly results due — last year filed 4 Dec 2025
Last quarter (Q3 2024, against a year earlier): revenue up 14%, net income down 10%
AIR's current read: News flow Balanced, Gap High · 27
GWRE · Guidewire Software, Inc. · Software / SaaS
Quarterly results due — last year filed 4 Dec 2025
Last quarter (Q3 2026, against a year earlier): revenue up 27%, net income down 64%
AIR's current read: News flow Balanced, Gap High · 44
NTNX · Nutanix, Inc. · Software / SaaS
Quarterly results due — last year filed 4 Dec 2025
Last quarter (Q3 2026, against a year earlier): revenue up 10%, net income up 14%
AIR's current read: News flow Balanced, Gap Medium · 22
REX · REX AMERICAN RESOURCES Corp · All industries
Quarterly results due — last year filed 4 Dec 2025
Last quarter (Q2 2027, against a year earlier): revenue up 6%, net income up 336%
AIR's current read: News flow Balanced, Gap Low · 0
SAIC · Science Applications International Corp · Software / SaaS
Quarterly results due — last year filed 4 Dec 2025
AIR's current read: News flow Balanced, Gap High · 39
SWBI · Smith & Wesson Brands, Inc. · Industrials
Quarterly results due — last year filed 4 Dec 2025
Last quarter (Q1 2027, against a year earlier): revenue up 32%, net income turned positive
AIR's current read: News flow Balanced, Gap Very high · 87
TITN · Titan Machinery Inc. · All industries
Quarterly results due — last year filed 4 Dec 2025
Last quarter (Q2 2027, against a year earlier): revenue down 9%, net loss widened
AIR's current read: News flow Balanced, Gap Low · 0
Expected dates come from each company's filing history. They are not forecasts, and companies move them.
Sign in to follow companies
Follow a company and its filings show up here.
Sign inResearch, not tips. Filings come from SEC EDGAR; AIR's read is recomputed every trading day. A price move is shown as a fact beside a filing, never as the reason it is listed.